Health·3,522 stories
Health News — Page 7
Enveda Raises $311M Series E at $2B Valuation
Colorado-based biotech startup Enveda, which uses AI to discover drugs derived from nature, raised a $311 million Series E at a $2 billion valuation—double its valuation from a year ago.
FDA Panel Endorses Grail Galleri Cancer Blood Test
An FDA advisory panel voted to endorse Grail's Galleri multi-cancer blood test, finding its benefits outweigh its risks — though the panel was sharply divided on whether the test actually works.
Enveda raises $311M to advance AI-discovered nature drugs
Enveda, a biotech that uses AI to mine plants and microbes for new medicines, has closed a $311 million Series E at a $2 billion valuation, doubling its worth in 12 months.
Anthropic: Claude autonomously finds Crispr-like enzyme
Anthropic says its AI Claude autonomously identified a previously uncharacterized enzyme system in bacteriophages during its newly launched wet lab's first major test, comparing the find to the gene-e
Bats originated in Europe, rewriting mammals’ family tree, study reveals
A landmark Nature study of 103 genomes and 44 fossils concludes bats originated in Europe roughly 65 million years ago, overturning prior assumptions about the mammals' family tree. The genomic 'code
Lifestyle changes may be as effective as therapy at easing depression
A trial of 267 adults with moderate-to-severe depression found that an eight-week remote lifestyle program — covering diet, exercise, sleep, and alcohol — reduced depression symptoms at least as much
Kent meningitis strain stole genes from harmless bacteria
A March outbreak of invasive meningococcal disease at a Canterbury nightclub infected 21 people and killed 2, and genomic analysis revealed the strain had stolen genes from harmless Neisseria bacteria
Will FDA advisers recommend a multi-cancer blood test for approval? They'll vote - NPR
FDA advisers will vote on whether to recommend Grail's multi-cancer blood test, which screens for 50 cancers and whose Medicare coverage hinges on FDA approval.
STAT+: A private equity-owned hospital chain is becoming a nonprofit. Is it just a bailout for investors?
Quorum Health, the private equity-owned chain of 11 mostly rural hospitals, is converting to nonprofit status — an unprecedented move the article questions as either a lifeline for struggling communit
New Push for Reproductive Psychiatry Board Certification
Opinion: A new nonprofit is racing to create the first US board certification in reproductive psychiatry, a field without formal subspecialty recognition despite more than 100,000 women with severe me
UnitedHealth, CVS Oppose Medicare Remote Monitoring Rule
UnitedHealth Group, CVS Health, and Kaiser Permanente wrote to CMS opposing a Medicare proposal that would require remote patient monitoring services be delivered only by direct employees of the billi
Pharma Revives Osteoporosis Drug Development
The pharmaceutical industry is showing renewed interest in osteoporosis treatments, driven by a long-awaited regulatory change, with Eli Lilly recruiting scientists and biotech VCs now prioritizing bo
Children as young as 13 are getting ketamine bladder damage
NHS medics at Liverpool's Alder Hey Hospital warn that ketamine is causing severe bladder damage in children as young as 13, with referrals to a new specialist clinic surging from one in 2023 to more
Cheap Eyelid Surgery Leaves Patients Unable to Close Eyes
A BBC investigation has found that dozens of women who traveled abroad for budget blepharoplasty — most to Dutch chain Faceland for around €750 — have suffered complications including eyes that won't
This new drug could break cancer’s resistance to treatment
Baylor College of Medicine researchers have developed an experimental drug called CS18 that simultaneously targets multiple cancer survival pathways and reversed drug resistance in lab and animal test
STAT+: HHS unveils new initiatives to reduce animal testing in drug development
HHS unveiled coordinated FDA and NIH initiatives to shift drug development away from animal testing, including an FDA final rule permitting non-animal safety studies and $88 million in NIH funding for
Opinion: Former FDA commissioners: Heidi Overton has an opportunity to strengthen the FDA
Former FDA commissioners Scott Gottlieb and Mark McClellan argue that nominee Heidi Overton has the experience and White House alignment to restore an FDA gutted by 3,500 layoffs and a growing biomedi
STAT+: Did the Trump administration just cut Novo a huge financial win?
Novo Nordisk may have secured an undisclosed additional benefit on top of its deal with the Trump administration to lower obesity drug costs for seniors, according to a paywalled STAT+ report.
Novo CEO sees weight-loss pills catching up to injectables by 2030
Novo Nordisk CEO Mike Doustdar said weight-loss pills could capture half the global obesity drug market by 2030, a forecast that would hand the Danish drugmaker a major advantage over rivals still foc
Pharma Fights for China Deal Carve-Out Under COINS
Western drugmakers are lobbying the Trump administration and Treasury Department to preserve their ability to strike deals with Chinese pharma companies, as new rules implementing the 2025 COINS law t
Get the Health newsletter
Curated health stories, every morning. Free.
No spam. Unsubscribe anytime.